FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nozomi Niitsu

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yuhko Suzuki; Tomiteru Togano; Guoqin Wang; Tsutomu Yoshida; Ryouichi Horie; Keiichi Iwabuchi; Shunsuke Miyamoto; Koji Miyazaki; Meijin Nakayama; Nozomi Niitsu; Yuichi Sato; Naoya Nakamura
Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
Yuhko Suzuki; Tsutomu Yoshida; Naoya Nakamura; Hirotoshi Kamata; Shouko Kotani; Manabu Ohsaka; Sabine Kajita; Koji Miyazaki; Shinichi Ohtani; Meijin Nakayama; Ryouichi Horie; Kazushige Hayakawa; Nozomi Niitsu; Masaaki Higashihara
CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases.
Yuhko Suzuki; Nozomi Niitsu; Miyuki Hayama; Takuji Katayama; Ryuji Ishii; Manabu Osaka; Koji Miyazaki; Mikio Danbara; Ryouichi Horie; Tsutomu Yoshida; Naoya Nakamura; Masaaki Higashihara
Lymphoproliferative disorders after immunosuppressive therapy for aplastic anemia: a case report and literature review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nozomi Niitsu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yuhko Suzuki; Tomiteru Togano; Guoqin Wang; Tsutomu Yoshida; Ryouichi Horie; Keiichi Iwabuchi; Shunsuke Miyamoto; Koji Miyazaki; Meijin Nakayama; Nozomi Niitsu; Yuichi Sato; Naoya Nakamura
Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
Annals of hematology 2012;91(7):997-1005.
2010: Yuhko Suzuki; Tsutomu Yoshida; Naoya Nakamura; Hirotoshi Kamata; Shouko Kotani; Manabu Ohsaka; Sabine Kajita; Koji Miyazaki; Shinichi Ohtani; Meijin Nakayama; Ryouichi Horie; Kazushige Hayakawa; Nozomi Niitsu; Masaaki Higashihara
CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases.
Internal medicine (Tokyo, Japan) 2010;49(16):1801-5.
2009: Yuhko Suzuki; Nozomi Niitsu; Miyuki Hayama; Takuji Katayama; Ryuji Ishii; Manabu Osaka; Koji Miyazaki; Mikio Danbara; Ryouichi Horie; Tsutomu Yoshida; Naoya Nakamura; Masaaki Higashihara
Lymphoproliferative disorders after immunosuppressive therapy for aplastic anemia: a case report and literature review.
Acta haematologica 2009;121(1):21-6.
2008: Nozomi Niitsu; Hirokazu Nakamine; Yuki Hagiwara; Ken Tanae; Ikuo Miura
The t(1;3)(p34;q27) translocation: a nonrandom BCL6 rearrangement in diffuse large B cell lymphoma.
Annals of hematology 2008;87(2):151-3.
2007: Nozomi Niitsu; Masataka Okamoto; Naoya Nakamura; Hirokazu Nakamine; Sadao Aoki; Masami Hirano; Ikuo Miura
Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Leukemia research 2007;31(9):1191-7.
2007: Miyuki Hayama; Nozomi Niitsu; Masaaki Higashihara; Hirokazu Nakamine; Ikuo Miura
t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma.
International journal of hematology 2007;86(2):147-9.
2007: Nozomi Niitsu; Masataka Okamoto; Naoya Nakamura; Hirokazu Nakamine; Masami Bessho; Masami Hirano
Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1203-8.
2007: Nozomi Niitsu; Masataka Okamoto; Tadashi Yoshino; Hirokazu Nakamine; Naoya Nakamura; Masami Bessho; Masami Hirano; Ikuo Miura
t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma.
Leukemia research 2007;31(5):707-11.
2007: Nozomi Niitsu
[The stratification treatment that was based on a prognostic factor of malignant lymphoma].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 1():534-9.
2007: Nozomi Niitsu; Mika Kohori; Masaaki Higashihara; Masami Bessho
Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma.
Cancer science 2007;98(1):109-12.
2006: Nozomi Niitsu; Masataka Okamoto; Mika Kohori; Sadao Aoki; Ikuo Miura; Masami Hirano
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.
Hematological oncology 2006;24(4):220-6.
2005: Naoki Wakimoto; Nozomi Niitsu
Lymphoid neoplasms associated with mosquito bites.
Internal medicine (Tokyo, Japan) 2005;44(11):1118-9.
2005: Nozomi Niitsu; Mika Kohri; Miyuki Hayama; Hirokazu Nakamine; Naoya Nakamura; Masami Bessho; Masaaki Higashihara
Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Leukemia research 2005;29(11):1361-4.
2005: Nozomi Niitsu; Mika Khori; Miyuki Hayama; Koichi Kajiwara; Masaaki Higashihara; Jun-ichi Tamaru
Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):697-702.
2004: Nozomi Niitsu; Mika Kohri; Tomiteru Togano; Hirokazu Nakamine; Shigeo Nakamura; Kei-ichi Iwabuchi; Masaaki Higashihara
Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
European journal of haematology 2004;73(5):367-71.
2004: Nozomi Niitsu; Miyuki Hayama; Masataka Okamoto; Mika Khori; Masaaki Higashihara; Jun-ichi Tamaru; Masami Hirano
Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4077-82.
2004: Kimiko Iijima; Yoshio Honma; Nozomi Niitsu
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid.
Leukemia & lymphoma 2004;45(5):1017-24.
2004: Nozomi Niitsu; Hirokazu Nakamine; Masataka Okamoto; Hiroko Akamatsu; Masaaki Higashihara; Yoshio Honma; Junko Okabe-Kado; Masami Hirano
Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2482-90.
2003: Nobu Akiyama; Hiroyuki Ohtake; Akira Ohwada; Kohichi Kajiwara; Miyuki Hayama; Mika Kohri; Miyako Taira; Nozomi Niitsu; Ryouichi Horie; Masaaki Higashihara
[Successful radiotherapy for the thoracic cord infiltration of adult T-cell leukemia/lymphoma].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2003;44(11):1095-100.
2003: Nozomi Niitsu; Hirokazu Nakamine; Masataka Okamoto; Hiroko Akamatsu; Yoshio Honma; Masaaki Higashihara; Junko Okabe-Kado; Masami Hirano
Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
British journal of haematology 2003;123(4):621-30.
2003: Nozomi Niitsu; Masataka Okamoto; Y Honma; Hirokazu Nakamine; Jun-ichi Tamaru; Shigeo Nakamura; T Yoshino; Masaaki Higashihara; Masami Hirano; Junko Okabe-Kado
Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma.
Leukemia 2003;17(5):987-90.
2003: Nozomi Niitsu; Hirokazu Nakamine; Mika Kohri; Miyuki Hayama; Jun-ichi Tamaru; Keiichi Iwabuchi; S Tanabe; Ryouichi Horie; Masaaki Higashihara
Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature.
Annals of hematology 2003;82(3):197-202.
2003: Nozomi Niitsu; Yoshio Honma; K Iijima; T Takagi; Masaaki Higashihara; U Sawada; Junko Okabe-Kado
Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Leukemia 2003;17(1):196-202.
2002: Nozomi Niitsu; Hirokazu Nakamine; Miyuki Hayama; Yumi Unno; Shigeo Nakamura; Ryouichi Horie; Keiichi Iwabuchi; Naoya Nakamura; Ikuo Miura; Masaaki Higashihara
Ovarian follicular lymphoma: a case report and review of the literature.
Annals of hematology 2002;81(11):654-8.
2002: Nozomi Niitsu; Masaaki Higashihara; Yoshio Honma
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Experimental hematology 2002;30(11):1273-82.
2002: Nobu Akiyama; Akira Ohwada; Kohichi Kajiwara; Hiroyuki Ohtake; Miyuki Hayama; Mika Kohri; Miyako Taira; Nozomi Niitsu; Ryouichi Horie; Masaaki Higashihara
[Granulocytic sarcoma of the colon in chronic myelomonocytic leukemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2002;43(10):937-42.
2002: Nozomi Niitsu; Masaaki Higashihara; Yoshio Honma
Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma.
Leukemia research 2002;26(8):745-55.
2002: Nozomi Niitsu; Kimiko Iijima
High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Leukemia research 2002;26(3):241-8.
2002: Nozomi Niitsu; Masataka Okamato; Hirokazu Nakamine; Tadashi Yoshino; Jun-ichi Tamaru; Shigeo Nakamura; Masaaki Higashihara; Masami Hirano
Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.
European journal of haematology 2002;68(2):91-100.
2001: Nozomi Niitsu; K Iijima
Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study.
Annals of hematology 2001;80(10):602-6.
2001: Nozomi Niitsu; K Iijima; A Chizuka
Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study.
Annals of hematology 2001;80(7):411-6.
2001: Miyuki Hayama; Nozomi Niitsu; Jun-ichi Tamaru; Masaaki Higashihara
[Primary lymphoma of the vagina].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2001;42(7):565-70.
2001: Nozomi Niitsu; Masataka Okamoto; Junko Okabe-Kado; T Takagi; T Yoshida; S Aoki; Yoshio Honma; Masami Hirano
Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
Leukemia 2001;15(5):832-9.
2001: Nozomi Niitsu; Junko Okabe-Kado; M Okamoto; T Takagi; T Yoshida; S Aoki; M Hirano; Yoshio Honma
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Blood 2001;97(5):1202-10.
2001: Nozomi Niitsu; Y Ishii; A Matsuda; Yoshio Honma
Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Cancer research 2001;61(1):178-85.
2001: Nozomi Niitsu; K Iijima; A Chizuka
A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
European journal of haematology 2001;66(1):24-30.
2000: K Sasaki; Nozomi Niitsu
Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
European journal of haematology 2000;65(3):195-202.
2000: Nozomi Niitsu; M Okamoto; Y Kuraishi; S Nakamura; F Kodama; M Hirano
CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study. The Adult Lymphoma Treatment Study Group (ALTSG).
European journal of haematology 2000;65(3):188-94.
2000: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; Takashi Kasukabe; Junko Okabe-Kado; M Umeda; Yoshio Honma
Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Blood 2000;96(4):1512-6.
2000: Nozomi Niitsu; Junko Okabe-Kado; M Nakayama; Naoki Wakimoto; Akiko Sakashita; Nobuo Maseki; Kazuo Motoyoshi; M Umeda; Yoshio Honma
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Blood 2000;96(3):1080-6.
2000: Nozomi Niitsu; Takashi Kasukabe; A Yokoyama; Junko Okabe-Kado; Yuri Yamamoto-Yamaguchi; M Umeda; Yoshio Honma
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.
Molecular pharmacology 2000;58(1):27-36.
2000: Nozomi Niitsu; A Chizuka; K Sasaki; Masanori Umeda
Human herpes virus-8 associated with two cases of primary-effusion lymphoma.
Annals of hematology 2000;79(6):336-9.
2000: Nozomi Niitsu; M Umeda; Yoshio Honma
Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Leukemia research 2000;24(1):1-9.
1999: Nozomi Niitsu; Junko Okabe-Kado; Takashi Kasukabe; Yuri Yamamoto-Yamaguchi; M Umeda; Yoshio Honma
Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
Blood 1999;94(10):3541-50.
1999: Nozomi Niitsu; Masanori Umeda
Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM.
European journal of haematology 1999;63(5):337-44.
1999: Nozomi Niitsu; K Sasaki; Masanori Umeda
A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Leukemia 1999;13(9):1434-40.
1999: Nozomi Niitsu; Yoshio Honma
Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Leukemia & lymphoma 1999;34(3-4):261-71.
1999: Nozomi Niitsu; M Nakayama; Masanori Umeda
[COP-BLAM therapy for a Hodgkin's disease in the elderly].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1999;36(6):412-5.
1998: Nozomi Niitsu; Y Yamaguchi; M Umeda; Yoshio Honma
Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Blood 1998;92(9):3368-75.
1998: Nozomi Niitsu; Masanori Umeda
Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkins's lymphoma.
Leukemia 1998;12(9):1457-60.
1998: Nozomi Niitsu; M Nakayama; Masanori Umeda
[A clinical study of primary lymphoma of bone].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1998;39(6):432-5.
1998: Nozomi Niitsu; Junichi Yamazaki; M Nakayama; Masanori Umeda
Pirarubicin-induced myocardial damage in elderly patients with non-Hodgkin's lymphoma.
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1998;35(5):358-62.
1998: Nozomi Niitsu; Masanori Umeda
[Clinical study of elderly patients with non-Hodgkin's lymphoma arising in the thyroid].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1998;35(1):39-43.
1997: Nozomi Niitsu; Masanori Umeda
THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study.
Leukemia 1997;11(11):1817-20.
1997: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; Y Kanatani; S Shuto; A Matsuda; M Umeda; Yoshio Honma
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
Experimental hematology 1997;25(12):1296-303.
1997: Nozomi Niitsu; M Umeda; Yoshio Honma
Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Biochemical and biophysical research communications 1997;238(1):100-6.
1997: Nozomi Niitsu; M Nakayama; M Kato; Masanori Umeda
[Non-Hodgkin's lymphoma associated with cold agglutinin disease].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1997;38(7):587-92.
1997: Nozomi Niitsu; Masanori Umeda
[Prognostic factors of follicular lymphoma treated with combination chemotherapy].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1997;38(6):496-504.
1997: Nozomi Niitsu; Masanori Umeda
Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma.
American journal of clinical oncology 1997;20(3):311-4.
1997: Nozomi Niitsu; M Nakayama; Masanori Umeda
[Effectiveness of prolonged oral therapy with low-dose etoposide in patients aged 85 years and over with non-Hodgkin's lymphoma].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1997;34(4):263-6.
1997: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; H Miyoshi; K Shimizu; M Ohki; M Umeda; Yoshio Honma
AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(3):319-26.
1997: Nozomi Niitsu
Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy.
Acta haematologica 1997;98(3):130-5.
1997: Nozomi Niitsu; M Kato; K Shikoshi; Masanori Umeda
[Doxorubicin-induced myocardial damage in elderly patients with hematologic malignancies].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1997;34(1):38-42.
1997: Nozomi Niitsu; M Nakayama; Masanori Umeda
[Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma].
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(1):61-6.
1996: Nozomi Niitsu; Junichi Yamazaki; Masanori Umeda
[Clinical usefulness of 123I-BMIPP (beta-methyl iodophenyl pentadecanoic (acid) myocardial SPECT in patients with hematological malignancies with adriamycin-induced cardiomyopathy].
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(13):1793-7.
1996: Nozomi Niitsu; Masanori Umeda
Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy.
European journal of haematology 1996;57(4):320-4.
1996: Nozomi Niitsu; Masanori Umeda
Angiocentric T cell lymphoma with prominent cutaneous ulceration.
Leukemia 1996;10(7):1249-51.
1996: Nozomi Niitsu; Masanori Umeda
[Double cancer in elderly patients with hematologic malignancies].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1996;33(4):269-72.
1996: Nozomi Niitsu; Masanori Umeda
Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
European journal of haematology 1996;56(3):163-7.
1996: Nozomi Niitsu; Masanori Umeda
Evaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma.
Acta haematologica 1996;96(1):36-40.
1995: Nozomi Niitsu; Masanori Umeda
[Assessment of cardiac toxicity by 123I-MIBG myocardial SPECT in elderly non-Hodgkin lymphoma patients treated with COP-BLAM and G-CSF].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1995;36(11):1326-8.
1995: Nozomi Niitsu; Junichi Yamazaki; M Nakayama; Masanori Umeda; T Morishita
[Usefulness of 123I-MIBG myocardial SPECT in patients with hematologic malignancies with chemotherapeutic agent-induced cardiomyopathy].
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(13):1941-5.
1995: T Shirai; H Kaneko; Nozomi Niitsu; H Katsunuma; M Mori; Y Murai
[Clinical analysis of elderly patients with malignant lymphoma].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1995;32(8-9):560-5.
1995: Nozomi Niitsu; M Nakayama; Masanori Umeda
[Chemotherapy with concomitant IFN treatment in three HBV carriers (mutant strain) with malignant lymphoma].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1995;36(8):780-5.
1995: Nozomi Niitsu; Masanori Umeda
COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
European journal of haematology 1995;55(2):88-92.
1995: Nozomi Niitsu; Masanori Umeda
[Usefulness of COP-BLAM therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1995;32(6):410-5.
1995: Nozomi Niitsu; Masanori Umeda
[Evaluation of respiratory tract disease accompanying malignant lymphoma in the elderly].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1995;32(4):266-9.
1995: Nozomi Niitsu; Masanori Umeda
[The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1995;36(2):84-90.
1994: Masanori Umeda; M Katoh; Nozomi Niitsu; M Takata; M Katoh; K Shikoshi
[VCAP chemotherapy combined with interferon-alpha (HLBI) for elderly multiple myeloma].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1994;31(12):969-74.
1994: Nozomi Niitsu; Masanori Umeda
[Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1994;35(11):1267-75.
1994: Nozomi Niitsu; Masanori Umeda
[3 cases of elderly malignant lymphoma of the thyroid gland].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1994;31(10):815-20.
1994: Nozomi Niitsu; Junichi Yamazaki; M Igarashi; Masanori Umeda; T Morishita
[Clinical usefulness of 123I-MIBG myocardial SPECT in patients with adriamycin-induced cardiomyopathy].
Kaku igaku. The Japanese journal of nuclear medicine 1994;31(9):1051-7.
1994: Nozomi Niitsu
[Evaluation of pulmonary function and bronchoalveolar lavage fluid in elderly non-Hodgkin's lymphoma before and after COP-BLAM III therapy].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1994;31(9):705-10.
1994: Nozomi Niitsu; Masanori Umeda
Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
International journal of hematology 1994;60(1):71-8.
1994: K Shikoshi; K Shikoshi; Nozomi Niitsu; M Takada; Masanori Umeda
[Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1994;31(6):468-71.
1994: Nozomi Niitsu
[Chronic daily administration of oral etoposide in elderly relapse or refractory lymphoma].
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(4):565-7.
1994: Nozomi Niitsu; K Shikoshi; Masanori Umeda; T Shirai
[Lennert's lymphoma associated with the syndrome of inappropriate secretion of antidiuretic hormone and autoimmune hemolytic anemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1994;35(1):80-4.
1993: Nozomi Niitsu; K Shikoshi; M Takata; Masanori Umeda
[A case of elderly Hashimoto disease presenting malignant lymphoma, gastric cancer and colon cancer].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1993;30(11):985-9.
1993: Nozomi Niitsu; Masanori Umeda; T Shirai
[COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1993;30(9):753-8.
1993: Nozomi Niitsu; H Kaneko; Masanori Umeda; T Shirai
[Elderly non-Hodgkin's lymphoma arising in left brachial soft tissue].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1993;30(8):720-4.
1993: Nozomi Niitsu; A Hara; Masanori Umeda; T Shirai
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1993;34(7):829-34.